亞洲知識產權資訊網為知識產權業界提供一個一站式網上交易平台,協助業界發掘知識產權貿易商機,並與環球知識產權業界建立聯繫。無論你是知識產權擁有者正在出售您的知識產權,或是製造商需要購買技術以提高操作效能,又或是知識產權配套服務供應商,你將會從本網站發掘到有用的知識產權貿易資訊。

Improved Treatment of Keloids and Other Cutaneous Fibrotic Diseases

技術應用
Treating keloid scars
詳細技術說明
Scarring is a widespread problem for patients of all walks of life. Patients with scars can encounter substantial social and psychological problems. Certain types of scarring can be particularly noticeable because they become raised after healing. These types of scars are characterized as hypertrophic or keloid scars. Keloid scarring is particularly problematic because the scar spreads beyond the margins of the original wound and invades surrounding skin. Ultraviolet phototherapy is currently used to treat some fibrotic skin diseases, however, this causes DNA damage associated with skin cancers. Researchers at UC Davis propose a method of treating keloid scars by administering specific doses of LED infrared or red light. Preliminary studies in vitro show that red light at specific wavelengths and dosages can be effective in decreasing fibroblast proliferation and migration. Researchers envision that the preliminary findings will serve as the foundation for future LED-based red and infrared light management of keloid and other scars.
*Abstract

Researchers at University of California, Davis have discovered that light emitting diode (LED) generated red light and infrared light can modulate skin cell functions associated with skin fibrosis.

*IP Issue Date
Jan 9, 2018
*Principal Investigation

Name: R. Rivkah Isseroff

Department:


Name: Jared Jagdeo

Department:


Name: Andrew Mamalis

Department:


Name: Neil Brody

Department:


Name: Hadar Lev-Tov

Department:


Name: Daniel Siegel

Department:

申請號碼
9861832
其他

Features/Benefits

  • Non-invasive
  • Low-cost
  • Safe for patient use at home
  • Portable
  • Easy to use
  • Small, handheld size

Tech ID/UC Case

23101/2013-520-0


Related Cases

2013-520-0

國家/地區
美國

欲了解更多信息,請點擊 這裡
移動設備